| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_766eae8ff319d5744cdadf9b32cf8baa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c88c5b3bc82bcedc5c4098d5d75e868e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 |
| filingDate |
2018-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4db1c1e63ca8651553d5cf5fa668a65b |
| publicationDate |
2020-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020282009-A1 |
| titleOfInvention |
Methods of treating diseases associated with vascular smooth muscle cell proliferation |
| abstract |
A method of treating a disease associated with vascular smooth muscle cell proliferation in a subject in need thereof is provided with the proviso that the disease is not cancer. The method comprises administering to the subject a therapeutically effective amount of a CXCR4-antagonistic peptide comprising SEQ ID NO: 1, thereby treating the disease. |
| priorityDate |
2017-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |